|
TTC26 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.7328300000008E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.083000E-03 |
| Normal-vs-Stage2 |
2.404500E-02 |
| Normal-vs-Stage3 |
2.09369999999431E-05 |
| Normal-vs-Stage4 |
7.415400E-04 |
| Stage1-vs-Stage2 |
6.298200E-01 |
| Stage1-vs-Stage3 |
6.860400E-02 |
| Stage1-vs-Stage4 |
2.437800E-01 |
| Stage2-vs-Stage3 |
4.635800E-01 |
| Stage2-vs-Stage4 |
6.955400E-01 |
| Stage3-vs-Stage4 |
7.181200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.01709999999978E-05 |
| Normal-vs-AfricanAmerican |
5.22059995233803E-09 |
| Normal-vs-Asian |
4.516000E-01 |
| Caucasian-vs-AfricanAmerican |
8.171400E-04 |
| Caucasian-vs-Asian |
2.905700E-02 |
| AfricanAmerican-vs-Asian |
6.430400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.69221999999358E-05 |
| Normal-vs-Female |
8.177100E-04 |
| Male-vs-Female |
3.520400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.438000E-01 |
| Normal-vs-Age(41-60Yrs) |
9.217100E-04 |
| Normal-vs-Age(61-80Yrs) |
1.63019999999126E-05 |
| Normal-vs-Age(81-100Yrs) |
4.17860000000436E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.955400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.861800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.559780E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.656800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.174580E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.382800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.694200E-02 |
| Normal-vs-Grade 2 |
1.241350E-03 |
| Normal-vs-Grade 3 |
4.176600E-04 |
| Normal-vs-Grade 4 |
4.22700000000109E-05 |
| Grade 1-vs-Grade 2 |
7.028800E-01 |
| Grade 1-vs-Grade 3 |
9.117400E-01 |
| Grade 1-vs-Grade 4 |
3.382600E-01 |
| Grade 2-vs-Grade 3 |
6.267400E-01 |
| Grade 2-vs-Grade 4 |
5.017800E-02 |
| Grade 3-vs-Grade 4 |
1.255580E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.886100E-02 |
| Normal-vs-ccB subtype |
4.27229999999668E-05 |
| ccA subtype-vs-ccB subtype |
1.384000E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.587800E-04 |
| Normal-vs-N1 |
7.604800E-01 |
| N0-vs-N1 |
3.724600E-01 |
|
|
